Postoperative non-opioid analgesics management;Comment utiliser les antalgiques non opiacés en postopératoire ?

Presse Medicale

Volumn 44, Issue 6, 2015, Pages 601-609

  Beloeil, Hélène ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NEFOPAM; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; STEROID; ANALGESIC AGENT;

ANALGESIA; FRANCE; HUMAN; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRESCRIPTION; SHORT SURVEY; TREATMENT INDICATION; DRUG COMBINATION; PAIN, POSTOPERATIVE;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; DRUG THERAPY, COMBINATION; HUMANS; PAIN MANAGEMENT; PAIN, POSTOPERATIVE;

EID: 84956596781     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2014.09.026     Document Type: Short Survey

References (80)

1. Dahl J.B., Rosenberg J., Dirkes W.E., Mogensen T., Kehlet H. Prevention of postoperative pain by balanced analgesia. Br J Anaesth 1990, 64:518-520.
2. Fletcher D., Aubrun F. [Long texts for the formalized recommendation of experts on management of postoperative pain]. Ann Fr Anesth Reanim 2009, 28:1-2.
3. Fletcher D., Fermanian C., Mardaye A., Aegerter P. A patient-based national survey on postoperative pain management in France reveals significant achievements and persistent challenges. Pain 2008, 137:441-451.
4. Van Aken H., Thys L., Veekman L., Buerkle H. Assessing analgesia in single and repeated administrations of propacetamol for postoperative pain: comparison with morphine after dental surgery. Anesth Analg 2004, 98:159-165.
5. McQuay H., Edwards J. Meta-analysis of single dose oral tramadol plus acetaminophen in acute postoperative pain. Eur J Anaesthesiol Suppl 2003, 28:19-22.
6. Aubrun F., Kalfon F., Mottet P., Bellanger A., Langeron O., Coriat P., et al. Adjunctive analgesia with intravenous propacetamol does not reduce morphine-related adverse effects. Br J Anaesth 2003, 90:314-319.
7. Juhl G.I., Norholt S.E., Tonnesen E., Hiesse-Provost O., Jensen T.S. Analgesic efficacy and safety of intravenous paracetamol (acetaminophen) administered as a 2g starting dose following third molar surgery. Eur J Pain 2006, 10:371-377.
8. Gregoire N., Hovsepian L., Gualano V., Evene E., Dufour G., Gendron A. Safety and pharmacokinetics of paracetamol following intravenous administration of 5g during the first 24h with a 2-g starting dose. Clin Pharmacol Ther 2007, 81:401-405.
9. Hylek E.M., Heiman H., Skates S.J., Sheehan M.A., Singer D.E. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998, 279:657-662.
10. Kakkar M., Derry S., Moore R.A., McQuay H.J. Single dose oral nefopam for acute postoperative pain in adults. Cochrane Database Syst Rev 2009, CD007442.
11. Bloomfield S.S., Barden T.P., Mitchell J. Nefopam and propoxyphene in episiotomy pain. Clin Pharmacol Ther 1980, 27:502-507.
12. Evans M.S., Lysakowski C., Tramer M.R. Nefopam for the prevention of postoperative pain: quantitative systematic review. Br J Anaesth 2008, 101:610-617.
13. Delage N., Maaliki H., Beloeil H., Benhamou D., Mazoit J.X. Median effective dose (ED50) of nefopam and ketoprofen in postoperative patients: a study of interaction using sequential analysis and isobolographic analysis. Anesthesiology 2005, 102:1211-1216.
14. Beloeil H., Eurin M., Thevenin A., Benhamou D., Mazoit J.X. Effective dose of nefopam in 80 % of patients (ED80): a study using the continual reassessment method. Br J Clin Pharmacol 2007, 64:686-693.
15. Corbonnois G., Iohom G., Lazarescu C., Hubert I., Bouaziz H. Unilateral permanent loss of vision after nefopam administration. Ann Fr Anesth Reanim 2013, 32:e113-e115.
16. Mimoz O., Chauvet S., Gregoire N., Marchand S., Le Guern M.E., Saleh A., et al. Nefopam pharmacokinetics in patients with end-stage renal disease. Anesth Analg 2010, 111:1146-1153.
17. Mitchell J.A., Warner T.D. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nat Rev Drug Discov 2006, 5:75-86.
18. Warner T.D., Mitchell J.A. COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Lancet 2008, 371:270-273.
19. Warner T.D., Giuliano F., Vojnovic I., Bukasa A., Mitchell J.A., Vane J.R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999, 96:7563-7568.
20. Derry C., Derry S., Moore R.A., McQuay H.J. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database Syst Rev 2009, CD001548.
21. Derry S., Barden J., McQuay H.J., Moore R.A. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev 2008, CD004233.
22. Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000, 343:1520-1528.
23. Silverstein F.E., Faich G., Goldstein J.L., Simon L.S., Pincus T., Whelton A., et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000, 284:1247-1255.
24. Laine L., Curtis S.P., Cryer B., Kaur A., Cannon C.P. Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients. Aliment Pharmacol Ther 2010, 32:1240-1248.
25. Kehlet H., Dahl J.B. Are perioperative nonsteroidal anti-inflammatory drugs ulcerogenic in the short term?. Drugs 1992, 44(Suppl. 5):38-41.
26. Strom B.L., Berlin J.A., Kinman J.L., Spitz P.W., Hennessy S., Feldman H., et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. JAMA 1996, 275:376-382.
27. Elia N., Lysakowski C., Tramer M.R. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology 2005, 103:1296-1304.
28. Desai J.C., Sanyal S.M., Goo T., Benson A.A., Bodian C.A., Miller K.M., et al. Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20mg in healthy subjects: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2008, 53:2059-2065.
29. Forrest J.B., Camu F., Greer I.A., Kehlet H., Abdalla M., Bonnet F., et al. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth 2002, 88:227-233.
30. Riggin L., Ramakrishna J., Sommer D.D., Koren G. A 2013 updated systematic review & meta-analysis of 36 randomized controlled trials; no apparent effects of non steroidal anti-inflammatory agents on the risk of bleeding after tonsillectomy. Clin Otolaryngol 2013, 38:115-129.
31. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999, 106:13S-24S.
32. Gambaro G., Perazella M.A. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med 2003, 253:643-652.
33. Zhang J., Ding E.L., Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA 2006, 296:1619-1632.
34. Bainbridge D., Cheng D.C., Martin J.E., Novick R. NSAID-analgesia, pain control and morbidity in cardiothoracic surgery. Can J Anaesth 2006, 53:46-59.
35. Acharya M., Dunning J. Does the use of non-steroidal anti-inflammatory drugs after cardiac surgery increase the risk of renal failure?. Interact Cardiovasc Thorac Surg 2010, 11:461-467.
36. Lee A., Cooper M.G., Craig J.C., Knight J.F., Keneally J.P. Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database Syst Rev 2007, 18:CD002765.
37. Solomon S.D., McMurray J.J., Pfeffer M.A., Wittes J., Fowler R., Finn P., et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005, 352:1071-1080.
38. Graham D.J., Campen D., Hui R., Spence M., Cheetham C., Levy G., et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005, 365:475-481.
39. Kearney P.M., Baigent C., Godwin J., Halls H., Emberson J.R., Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006, 332:1302-1308.
40. McGettigan P., Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006, 296:1633-1644.
41. Farkouh M.E., Kirshner H., Harrington R.A., Ruland S., Verheugt F.W., Schnitzer T.J., et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 2004, 364:675-684.
42. Trelle S., Reichenbach S., Wandel S., Hildebrand P., Tschannen B., Villiger P.M., et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011, 342:c7086.
43. Gislason G.H., Jacobsen S., Rasmussen J.N., Rasmussen S., Buch P., Friberg J., et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation 2006, 113:2906-2913.
44. Pope J.E., Anderson J.J., Felson D.T. A meta-analysis of the effects of non steroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993, 153:477-484.
45. Gislason G.H., Rasmussen J.N., Abildstrom S.Z., Schramm T.K., Hansen M.L., Fosbol E.L., et al. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 2009, 169:141-149.
46. Mamdani M., Juurlink D.N., Lee D.S., Rochon P.A., Kopp A., Naglie G., et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004, 363:1751-1756.
47. Krijthe B.P., Heeringa J., Hofman A., Franco O.H., Stricker B.H. Non-steroidal anti-inflammatory drugs and the risk of atrial fibrillation: a population-based follow-up study. BMJ Open 2014, 4:e004059.
48. Nussmeier N.A., Whelton A.A., Brown M.T., Langford R.M., Hoeft A., Parlow J.L., et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005, 352:1081-1091.
49. Nussmeier N.A., Whelton A.A., Brown M.T., Joshi G.P., Langford R.M., Singla N.K., et al. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology 2006, 104:518-526.
50. Schug S.A., Joshi G.P., Pan S., Cheung R. Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postopertavie setting: an analysis of integrated data. Anesthesia Analgesia 2009, 108:299-307.
51. Liu S.S., Bae J.J., Bieltz M., Ma Y., Memtsoudis S. Association of perioperative use of nonsteroidal anti-inflammatory drugs with postoperative myocardial infarction after total joint replacement. Reg Anesth Pain Med 2012, 37:45-50.
52. Mangano D.T., Siliciano D., Hollenberg M., Leung J.M., Browner W.S., Goehner P., et al. Postoperative myocardial ischemia. Therapeutic trials using intensive analgesia following surgery. The Study of Perioperative Ischemia (SPI) Research Group. Anesthesiology 1992, 76:342-353.
53. Beattie W.S., Warriner C.B., Etches R., Badner N.H., Parsons D., Buckley N., et al. The addition of continuous intravenous infusion of ketorolac to a patient-controlled analgetic morphine regime reduced postoperative myocardial ischemia in patients undergoing elective total hip or knee arthroplasty. Anesth Analg 1997, 84:715-722.
54. Catella-Lawson F., Reilly M.P., Kapoor S.C., Cucchiara A.J., DeMarco S., Tournier B., et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001, 345:1809-1817.
55. Schuijt M.P., Huntjens-Fleuren H.W., de Metz M., Vollaard E.J. The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers. Br J Pharmacol 2009, 157:931-934.
56. Rimon G., Sidhu R.S., Lauver D.A., Lee J.Y., Sharma N.P., Yuan C., et al. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1. Proc Natl Acad Sci U S A 2010, 107:28-33.
57. MikealoffY., Kezouh A., Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicelle or zoster disease. Br J Pharmacol 2008, 65:203-209.
58. Legras A., Giraudeau B., Jonville-Bera A.P., Camus C., Francois B., Runge I., et al. A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock. Crit Care 2009, 13:R43.
59. Bernard G.R., Wheeler A.P., Russell J.A., Schein R., Summer W.R., Steinberg K.P., et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997, 336:912-918.
60. Ott E., Nussmeier N.A., Duke P.C., Feneck R.O., Alston R.P., Snabes M.C., et al. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003, 125:1481-1492.
61. Rapuano B.E., Boursiquot R., Tomin E., Macdonald D.E., Maddula S., Raghavan D., et al. The effects of COX-1 and COX-2 inhibitors on prostaglandin synthesis and the formation of heterotopic bone in a rat model. Arch Orthop Trauma Surg 2008, 128:333-344.
62. Fransen M., Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004, CD001160.
63. Fransen M., Anderson C., Douglas J., MacMahon S., Neal B., Norton R., et al. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ 2006, 333:519.
64. Vuolteenaho K., Moilanen T., Moilanen E. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol 2008, 102:10-14.
65. Klein M., Gogenur I., Rosenberg J. Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective data. BMJ 2012, 345:e6166.
66. Burton T.P., Mittal A., Soop M. Nonsteroidal anti-inflammatory drugs and anastomotic dehiscence in bowel surgery: systematic review and meta-analysis of randomised controlled trials. Dis Colon Rectum 2013, 56:126-134.
67. Alfonsi P., Slim K., Chauvin M., Mariani P., Faucheron J.L., Fletcher D., et al. [Guidelines for enhanced recovery after elective colorectal surgery]. Ann Fr Anesth Reanim 2014, 33:370-384.
68. De Oliveira G.S., Almeida M.D., Benzon H.T., McCarthy R.J. Perioperative Single Dose Systemic Dexamethasone for Postoperative Pain: A Meta-analysis of Randomized Controlled Trials. Anesthesiology 2012, 115:575-588.
69. Bolac C.S., Wallace A.H., Broadwater G., Havrilesky L.J., Habib A.S. The impact of postoperative nausea and vomiting prophylaxis with dexamethasone on postoperative wound complications in patients undergoing laparotomy for endometrial cancer. Anesth Analg 2013, 116:1041-1047.
70. Bellis J.R., Pirmohamed M., Nunn A.J., Loke Y.K., De S., Golder S., et al. Dexamethasone and haemorrhage risk in paediatric tonsillectomy: a systematic review and meta-analysis. Br J Anaesth 2014, 113:23-42.
71. Van Elstraete A.C., Sitbon P. Median effective dose (ED50) of paracetamol and nefopam for postoperative pain: isobolographic analysis of their antinociceptive interaction. Minerva Anestesiol 2013, 79:232-239.
72. Girard P., Niedergang B., Pansart Y., Coppe M.C., Verleye M. Systematic evaluation of the nefopam-paracetamol combination in rodent models of antinociception. Clin Exp Pharmacol Physiol 2011, 38:170-178.
73. Ong C.K., Seymour R.A., Lirk P., Merry A.F. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg 2010, 110:1170-1179.
74. Miranda H.F., Puig M.M., Prieto J.C., Pinardi G. Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain 2006, 121:22-28.
75. Naesh O., Niles L.A., Gilbert J.G., Ammar M.M., Phibbs P.W., Phillips A.M., et al. A randomized, placebo-controlled study of rofecoxib with paracetamol in early post-tonsillectomy pain in adults. Eur J Anaesthesiol 2005, 22:768-773.
76. Maund E., McDaid C., Rice S., Wright K., Jenkins B., Woolacott N. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review. Br J Anaesth 2011, 106:292-297.
77. Marret E., Kurdi O., Zufferey P., Bonnet F. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials. Anesthesiology 2005, 102:1249-1260.
78. Nikanne E., Kokki H., Salo J., Linna T.J. Celecoxib and ketoprofen for pain management during tonsillectomy: a placebo-controlled clinical trial. Otolaryngol Head Neck Surg 2005, 132:287-294.
79. Hegi T.R., Bombeli T., Seifert B., Baumann P.C., Haller U., Zalunardo M.P., et al. Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac. Br J Anaesth 2004, 92:523-531.
80. Murphy G.S., Szokol J.W., Greenberg S.B., Avram M.J., Vender J.S., Nisman M., et al. Preoperative Dexamethasone Enhances Quality of Recovery after Laparoscopic Cholecystectomy: Effect on In-hospital and Postdischarge Recovery Outcomes. Anesthesiology 2011, 114:882-890.